Permanent J Code Issued for Avedro's Photrexa® Drug Formulations

BUSINESS WIRE)--Nov 20, 2018--Avedro, Inc., a leading commercial-stage ophthalmic medical technology company and a global leader in corneal ...

source https://www.oaoa.com/news/business/article_faa5f95f-4c77-58c9-953e-321c56ae7494.html